The trading price of Zoetis Inc. (NYSE:ZTS) floating lower at last check on Wednesday, May 24, closing at $169.14, -2.05% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $171.40 and $177.98. The company’s P/E ratio in the trailing 12-month period was 39.00, while its 5Y monthly beta was 0.76. In examining the 52-week price action we see that the stock hit a 52-week high of $187.82 and a 52-week low of $124.15. Over the past month, the stock has lost -2.24% in value.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Zoetis Inc., whose market valuation is $79.87 billion at the time of this writing, is expected to release its quarterly earnings report Aug 02, 2023 – Aug 07, 2023. The dividend yield on the company stock is 0.87%, while its Forward Dividend ratio is 1.50. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $1.32 per share this quarter, however they have predicted annual earnings per share of $5.4 for 2023 and $6.07 for 2024. It means analysts are expecting annual earnings per share growth of 10.70% this year and 12.40% next year.
Analysts have forecast the company to bring in revenue of $2.17 billion for the current quarter, with the likely lows of $2.1 billion and highs of $2.19 billion. The average estimate suggests sales will likely up by 5.70% this quarter compared to what was recorded in the comparable quarter last year. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2023 is $8.63 billion. The company’s revenue is forecast to grow by 6.80% over what it did in 2023.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Zoetis Inc. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ZTS has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned ZTS a recommendation rating is 15. Out of them, 1 rate it a Hold, while 11 recommend Buy, whereas 3 assign an Overweight rating. 0 analyst(s) have tagged Zoetis Inc. (ZTS) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 3.51, which symbolizes a positive outlook. A quick review shows that ZTS’s price is currently -6.04% off the SMA20 and -2.34% off the SMA50. The RSI metric on the 14-day chart is currently showing 33.15, and weekly volatility stands at 2.47%. When measured over the past 30 days, the indicator reaches 2.43%. Zoetis Inc. (NYSE:ZTS)’s beta value is currently sitting at 0.76, while the Average True Range indicator is currently displaying 4.10. With analysts defining $185.00-$260.00 as the low and high price targets, we arrive at a consensus price target of $218.27 for the trailing 12-month period. The current price is about -9.38% off the estimated low and -53.72% off the forecast high, based on this estimate. Investors will be thrilled if ZTS’s share price rises to $210.00, which is the median consensus price. At that level, ZTS’s share price would be -24.16% below current price.
To see how Zoetis Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: ZTS stock’s performance was -2.05% at last check in today’s session, and 3.77% in the past year, while Merck & Co. Inc. (MRK) has been trading 0.13% in recent session and positioned 20.88% higher than it was a year ago. Another comparable company IDEXX Laboratories Inc. (IDXX) saw its stock trading -0.51% lower in today’s session but was up 24.54% in a year. Zoetis Inc. has a P/E ratio of 39.00, compared to Merck & Co. Inc.’s 22.10 and IDEXX Laboratories Inc.’s 55.48. Also during today’s trading, the S&P 500 Index has plunged -0.87%, while the Dow Jones Industrial also saw a negative session, down -0.69% today.
An evaluation of the daily trading volume of Zoetis Inc. (NYSE:ZTS) indicates that the 3-month average is 1.82 million. However, this figure has increased over the past 10 days to an average of 1.62 million.
Currently, records show that 463.50 million of the company’s shares remain outstanding. The insiders hold 0.20% of outstanding shares, whereas institutions hold 94.50%. The stats also highlight that short interest as of Apr 27, 2023, stood at 4.55 million shares, resulting in a short ratio of 3.12 at that time. From this, we can conclude that short interest is 0.98% of the company’s total outstanding shares. It is noteworthy that short shares in April were down slightly from the previous month’s figure, which was 5.07 million. However, since the stock’s price has seen 15.41% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.